Hironobu Murakami, Yuuta Fujikawa, Masaya Mori, Nozomi Mosu, Akihiro Taguchi, Yoshio Hayashi, Hideshi Inoue, Shinji Kamisuki. Development of a novel fluorogenic assay method for screening inhibitors of bovine leukemia virus (BLV) protease and identification of mitorubrinic acid as an anti-BLV compound. Bioscience, biotechnology, and biochemistry. 2023
Kou Nakamura, Masako Yamasaki, Hirofumi Ohashi, Shiki Saito, Koudai Ashikawa, Kanna Sato, Kazane Nishioka, Yuka Suzuki, Yukine Tsurukawa, Kazuki Kanno, et al. Identification of methylsulochrin as a partial agonist for aryl hydrocarbon receptors and its antiviral and anti-inflammatory activities. Chemical & pharmaceutical bulletin. 2023
Shinji Kamisuki, Hisanobu Shibasaki, Hironobu Murakami, Kan Fujino, Senko Tsukuda, Ikumi Kojima, Koudai Ashikawa, Kazuki Kanno, Tomohiro Ishikawa, Tatsuo Saito, et al. Isolation, structural determination, and antiviral activities of metabolites from vanitaracin A-producing Talaromyces sp. The Journal of antibiotics. 2023. 76. 2. 75-82
Hirofumi Ohashi, Kazane Nishioka, Tomoki Kurihara, Kou Nakamura, Masako Yamasaki, Yuuka Ibayashi, Kanta Fuchiyama, Shogo Kamo, Yuuki Furuyama, Kenji Ohgane, et al. Anti-hepatitis C Virus Activity of Juglorubin Derivatives. Chemical & pharmaceutical bulletin. 2023. 71. 11. 843-845
Rimina Suzuki, Mayuko Mishima, Masaki Nagane, Hinano Mizugaki, Takehito Suzuki, Mariko Komuro, Takuto Shimizu, Tomoki Fukuyama, Shiro Takeda, Masaya Ogata, et al. The novel sustained 3-hydroxybutyrate donor poly-D-3-hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T-cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2023. 37. 1. e22708